Looking to publish in Neurodegenerative Disease Management? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginNeurodegenerative Disease Management is a MEDLINE-indexed, peer-reviewed journal focused on treatment strategies, emerging research, and multidisciplinary management of neurodegenerative diseases. It covers topics including disease mechanisms, epidemiology, diagnosis, biomarkers, therapeutic options, cognitive impairment and dementia, new treatments such as cell and gene therapy, pharmacoeconomics, real-world evidence, quality of life, and palliative care. Articles are peer reviewed by three independent referees on a double-blind basis, and the journal welcomes unsolicited article proposals.
Looking to publish in Neurodegenerative Disease Management? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer loginSubmission Instructions
Neurodegenerative Disease Management accepts the following article types. Click on an article type to view submission instructions.
Review Articles
Original Research
Drug Evaluation Articles
Recent Publications
Aqueous extracts of Phyllanthus amarus leaf mitigate cognitive impairments by enhancing neurotransmitter regulation and antioxidant defense mechanisms
Bukola Christiana Adedayo, Idowu Sunday Oyeleye, Olayinka Sakiru Oyelami, Olayemi Philemon Aro, Olajide Raymond Ojo, Ganiyu Oboh
Dual targeting of melatonergic and serotonergic neurotransmissions in Parkinson’s disease: role of agomelatine
Hayder M. Al-Kuraishy, Marwa Thaier Naji, Raghad Rahem Abd Hasan, Duaa Eliwa, Gaber El-Saber Batiha
Molecular and genetic basis of alzheimer’s disease and emerging treatment Modalities
Himanshi Varshney, Yasir Hasan Siddique
Trends in mortality of Alzheimer’s disease with comorbid hypertension in patients in the US from 1999–2020
Sana Shahbaz, Muhammad Hassan Shahbaz, Rauha Fatima, Muhammad Hussain Mansoor, Maryam Kharal, Maryam Bashir, Zain Ul Abideen, Muhammad Salman Nadeem
Estrogen and progesterone receptor signaling as candidate neuroendocrine modulators in Huntington’s disease
John Carlson
Frequently asked questions
How long does it take to publish?
Accelerated Publication offers a final decision in as little as 3 weeks or 9 weeks from submission. Online publication usually occurs 1-2 weeks or 2-3 weeks after acceptance. First proofs are provided within 5 working days.
Reformat to Neurodegenerative Disease Management using Livewrite PremiumIs a cover letter required?
Journals may require authors, prior to acceptance, to sign a letter certifying that legal and ethical requirements for humane animal treatment have been met.
Reformat to Neurodegenerative Disease Management using Livewrite PremiumWhat are the publication costs?
Subscription journal. Individual subscription prices are USD 2,491.00 for online only and USD 3,642.00 for print and online.
Reformat to Neurodegenerative Disease Management using Livewrite Premium